| Tretinoin | Approved Investigational Nutraceutical | RTTN | 25914 |
downregulated | Tretinoin results in decreased expression of RTTN mRNA | 18q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RUBCNL | 80183 |
upregulated | Tretinoin results in increased expression of RUBCNL mRNA | 13q14.13 | |
| Tretinoin | Approved Investigational Nutraceutical | RUFY2 | 55680 |
upregulated | Tretinoin results in increased expression of RUFY2 mRNA | 10q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | RUFY3 | 22902 |
upregulated | Tretinoin results in increased expression of RUFY3 mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | RUNDC3B | 154661 |
upregulated | Tretinoin results in increased expression of RUNDC3B mRNA | 7q21.12 | |
| Tretinoin | Approved Investigational Nutraceutical | RUNX1 | 861 |
downregulated | Tretinoin results in decreased expression of RUNX1 mRNA | 21q22.12 | |
| Tretinoin | Approved Investigational Nutraceutical | RUNX2 | 860 |
downregulated | Tretinoin results in decreased expression of RUNX2 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RUNX2 | 860 |
upregulated | Tretinoin results in increased expression of RUNX2 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RUVBL2 | 10856 |
downregulated | Tretinoin results in decreased expression of RUVBL2 mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | RXFP2 | 122042 |
upregulated | Tretinoin results in increased expression of RXFP2 mRNA | 13q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RXRA | 6256 |
upregulated | Tretinoin results in increased expression of RXRA mRNA | 9q34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RXRB | 6257 |
upregulated | Tretinoin results in increased expression of RXRB mRNA | 6p21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | RXRG | 6258 |
downregulated | Tretinoin results in decreased expression of RXRG mRNA | 1q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | RXRG | 6258 |
upregulated | Tretinoin results in increased expression of RXRG mRNA | 1q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A1 | 6271 |
downregulated | Tretinoin metabolite results in decreased expression of S100A1 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A10 | 6281 |
upregulated | Tretinoin results in increased expression of S100A10 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A11 | 6282 |
upregulated | Tretinoin results in increased expression of S100A11 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A14 | 57402 |
downregulated | Tretinoin results in decreased expression of S100A14 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A16 | 140576 |
downregulated | Tretinoin results in decreased expression of S100A16 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A4 | 6275 |
downregulated | Tretinoin results in decreased expression of S100A4 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A4 | 6275 |
upregulated | Tretinoin results in increased expression of S100A4 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A7 | 6278 |
upregulated | Tretinoin metabolite results in increased expression of S100A7 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A7 | 6278 |
upregulated | Tretinoin results in increased expression of S100A7 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A8 | 6279 |
upregulated | Tretinoin metabolite results in increased expression of S100A8 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | S100A8 | 6279 |
downregulated | Tretinoin results in decreased expression of S100A8 mRNA | 1q21.3 | |